VanDerGinst Law Home What VLAW Can Do For You VanDerGinst Law Commitment Meet The VanDerGinst Law Team VanDerGinst Law Testimonials VanDerGinst Law News VanDerGinst Law Community Events Espanol Contact VanDerGinst Law
Inauguration Photos
Free Downloadable Law Brochures
Online Law Library
The Civil Justice System
The Civil Justice System Know Your Rights The Lawyers Role
Attorneys Help UnSung Heroes Consumer Attorneys Care VLAW Pod-casts
VLAW Pod-casts

Holiday Bash

Accident Cases Dangerous Drugs Medical Devices Defective Products
Pollutants Medical Malpractice Consumer Fraud Other Resources
Our Scrapbook Legal Dictionary For Injury Clients Home Safety Tips
Lawyer Values Message to Attorneys Chicago Injury Lawyer Articles

Advair

The Advair Diskus inhaler provides relief to sufferers of asthma. The combination of the drugs fluticasone and salmeterol shrinks the swelling of breathing passages, providing relief to the patient. It received approval by the FDA in the year 2000.

Soon after the approval, studies began to show a marked increase in the risk for "serious" asthma attacks when an Advair Diskus or a similar drug was used by a patient. While short-term symptoms were relieved, the chance for more developed and serious symptoms increased.

Use of Advair can have the following dangerous, unintended side effects: bronchitis, cough, diarrhea, difficulty speaking, muscle and bone pain, vomiting, headaches, stomach pain, hoarseness, nausea, sore throat, fungal infection of the mouth, and sinus pain. If you believe you have experienced any of these symptoms, or a severe asthma attack, as the result of your use of Advair, contact an experienced Advair attorney from our firm as soon as you can.

In August 2003, the FDA announced new safety information and warnings to the labeling for drug products, such as Advair inhalers, that contain salmeterol. The annoucnement included a new boxed warning about a small, but significant, increased risk of life-threatening asthma episodes or asthma-related deaths observed in patients using salmeterol-based drugs in a recently completed large U.S. safety study.

On May 16, 2006, The FDA announced that the product label for Advair has been updated with a warning detailing the increased risk of severe asthma or death.

If you or a loved one has suffered an injury, illness or death, that seems to have been someone else’s fault, call VanDerGinst Law at 1-866-843-7367 or click here for a FREE online case evaluation. The initial consultation is free of charge. If we agree to handle your injury case, we will work on a contingency fee basis, which means we get paid for our services only if, and when, there is a money recovery for you. In many cases a lawsuit must be filed before an applicable expiration date, known as a statute of limitations. So please call right away to ensure that you do not waive your right to possible compensation.

Advair, Injury, MayAdvair, Injury, May
No fee unless we win your accident or injury case. Fields with * must be filled in.

* Full Name
* Email Address
* Phone Number
Cell Number
Address including City, State, & Zip Code
Date of Birth of Injured Person
State Where Accident/Incident Occurred
Describe Accident/Incident and Injuries
Yes, I agree to the VanDerGinst Law disclaimers. Review the disclaimers.
Yes, I would like to receive the VanDerGinst Law Monthly E-Newsletter.
Advair, Injury, May
Advair, Injury, May
Advair, Injury, May
Advair, Injury, May

500 Million Eggs Recalled…and Counting
The salmonella-infected egg recall continues to expand. The eggs, which have sickened more than 1,000 consumers since at least May are thought to be i...

WHO Studies Cancer, Cell Phone Link - Results Inconclusive
The World Health Organization (WHO) announced that its International Agency for Research on Cancer (IARC) study on the relationship between cell phone...

Iowa Filing Suit Against Louisiana Used Car Dealer
Iowa’s Attorney General is taking action against Smart Automotive Group of Louisiana for “false-premise” used car sales promotions in Iowa. Most...

Advair, Injury, May
Advair, Injury, May
Advair, Injury, May